Companies: 10,795·Total market cap: $144.5T
Sesen Bio, Inc.

Sesen Bio, Inc.

SESNNASDAQHealthcare
$0.63
+$0.04(+7.29%)
Market Cap$127955770
P/E Ratio—
52W High$0.965
52W Low$0.365
SEC Filings

Sesen Bio, Inc. (SESN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001485003 · SESN · NASDAQ · as of Jun 8, 2026

Filing snapshot

853
Total Filings
15-12G
Latest Form
2025-12-29
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001485003 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-04-29
Fiscal Year End
Apr 29, 2025
Accession No.
0001628280-25-020724
Primary Document
carm-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001485003 · Accession 0001628280-25-020724

Latest Key Filings

10-QQuarterly Report
10-Q
2025-11-12
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2025-12-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2025-12-29
View
EFFECTEFFECT
EFFECT
2025-12-16
View
EFFECTEFFECT
EFFECT
2025-12-16
View
EFFECTEFFECT
EFFECT
2025-12-16
View
EFFECTEFFECT
EFFECT
2025-12-16
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
S-8 POSS-8 POS
S-8 POS
2025-12-15
View
Showing 1–15 of 661 filingsForm 4 / 144 hidden· 853 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001485003  |  Exchange: NASDAQ · Healthcare

Sesen Bio, Inc. (NASDAQ: SESN) has submitted 853 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001485003, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Sesen Bio, Inc.'s most comprehensive regulatory disclosure. The most recent Sesen Bio, Inc. 10-K was filed on 2025-04-29 for fiscal year ending 2025. Historical SESN 10-K annual reports are available from 2010 through 2025.

Investors researching Sesen Bio, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
TRML SEC Filings →SELB SEC Filings →PRDS SEC Filings →NGM SEC Filings →PRTK SEC Filings →KNTE SEC Filings →DBTX SEC Filings →GRAY SEC Filings →
→ SESN Financials→ SESN Earnings→ SESN Insider Trades

Frequently Asked Questions

SESN SEC Filings · 8 questions

Sesen Bio, Inc. (SESN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 853 filings and access original documents at no cost. Sesen Bio, Inc.'s CIK is 0001485003.

SESN SEC filingsSesen Bio, Inc. SEC documentsfind SESN 10-K